MONEY Inovio wins case in dispute with VGXI, GeneOne Life Science (INO:NASDAQ) Oct 20, 2026 Finance Desk bymuratdeniz/iStock via Getty Images Inovio Pharmaceutical (INO) won an $80.4M judgment in a lawsuit that accused VGXI and GeneOne Life Sciences of violating a supply agreement. Inovio argued that the two companies declined to abide by technology transfer obligations that would have allowed Source link
